CSIMarket
 
Heska Corporation  (HSKA)
Other Ticker:  
 
 

Heska Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2023, Heska's inventory turnover ratio sequentially decreased to 2.45 in the first quarter 2023, unsurprisingly, as the Heska markets continue to deteriorate, and HSKA's faces growing challenges to bring down its inventories. Heska's average inventory processing period in the Mar 31 2023 quarter, has increased to 149 days, from 143 days, in the Dec 31 2022 quarter.

Within Healthcare sector 176 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2023, to 1196, from total ranking in the forth quarter 2022 at 1362.

HSKA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Heska Corporation Market Share?

What is Inventory Turnover Ratio?


HSKA Inventory Turnover Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Inventory Growth 16.23 % 21.65 % 27.62 % 35.42 % 40.31 %
Y / Y Cost of Sales Growth -1.89 % -4.32 % -1.09 % -0.82 % 1.78 %
Inventory Turnover Ratio (TTM) 2.45 2.56 2.72 2.89 3.11
HSKA's Total Ranking # 1196 # 1362 # 1464 # 1396 # 1105
Average inventory processing period 149 143 134 126 117
Seq. Inventory Growth 6.88 % 4.48 % 3.01 % 1.04 % 11.87 %
Seq. Cost of Sales Growth -9.18 % 11.28 % -7.32 % 4.75 % -11.44 %



Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 7
Healthcare Sector # 177
Overall Market # 1196

Inventory Turnover Ratio Statistics
High Average Low
4.35 3.22 2.31
(Dec. 30, 2014)   (Sep 30 2018)




Financial Statements
Heska's Inventories $ 64 Millions Visit HSKA's Balance sheet
Heska's Cost of Revenues TTM $ 145 Millions Visit HSKA's Income Statement
What are HSKA's Sales? Visit HSKA's Sales by Segment

Other Inventory Turnover Ratios
Heska's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HSKA's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HSKA's Competitors
Inventory Turnover Ratio for HSKA's Suppliers
Inventory Turnover Ratio for HSKA's Customers

You may also want to know
HSKA's Sales Growth Rates HSKA's Pe Price to earnings ratio HSKA's Receivables Turnover Ratio HSKA's Stock Quote
HSKA's Net Income Growth Rates HSKA's Ps Price to Sales ratio HSKA's Sales per Employee HSKA's Asset Turnover Ratio
HSKA's Net Margin HSKA's Pb Price to Book ratio HSKA's Financial Strength Ratios HSKA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Inogen Inc   6.18 $ 219.758  Millions$ 36  Millions
Hims and Hers Health Inc   6.12 $ 128.981  Millions$ 21  Millions
Fonar Corporation  6.09 $ 15.402  Millions$ 3  Millions
Patterson Companies Inc   5.85 $ 5,098.526  Millions$ 872  Millions
Genedx Holdings Corp   5.85 $ 163.355  Millions$ 28  Millions
Owens and Minor inc  5.74 $ 8,121.162  Millions$ 1,414  Millions
Veracyte inc   5.53 $ 77.442  Millions$ 14  Millions
Carlisle Companies Incorporated  5.47 $ 4,261.200  Millions$ 779  Millions
Cryoport inc   5.47 $ 139.188  Millions$ 25  Millions
Alimera Sciences Inc   5.32 $ 8.325  Millions$ 2  Millions
Cti Biopharma Corp   5.31 $ 4.460  Millions$ 1  Millions
Avantor Inc   5.27 $ 4,804.600  Millions$ 911  Millions
Ufp Technologies Inc   5.19 $ 278.476  Millions$ 54  Millions
Integer Holdings Corporation  5.10 $ 1,069.765  Millions$ 210  Millions
Exact Sciences Corporation  5.05 $ 596.555  Millions$ 118  Millions
Horizon Therapeutics Public Limited Company  5.02 $ 913.698  Millions$ 182  Millions
Abbvie inc   4.96 $ 17,348.000  Millions$ 3,495  Millions
Incyte Corporation  4.83 $ 221.205  Millions$ 46  Millions
Adm Tronics Unlimited Inc   4.80 $ 2.019  Millions$ 0  Millions
Catalyst Pharmaceuticals Inc   4.79 $ 38.449  Millions$ 8  Millions
Codex Dna Inc   4.74 $ 10.023  Millions$ 2  Millions
Inspire Medical Systems inc   4.71 $ 75.999  Millions$ 16  Millions
Aquestive Therapeutics Inc   4.68 $ 28.685  Millions$ 6  Millions
Henry Schein Inc  4.63 $ 8,704.000  Millions$ 1,881  Millions
Cytosorbents Corporation  4.57 $ 15.672  Millions$ 3  Millions
Precision Optics Corporation Inc   4.55 $ 13.186  Millions$ 3  Millions
Vystar Corporation  4.51 $ 7.531  Millions$ 2  Millions
Invacare Holdings Corporation  4.50 $ 534.718  Millions$ 119  Millions
Eargo Inc   4.47 $ 24.188  Millions$ 5  Millions
Bristol myers Squibb Company  4.47 $ 10,232.000  Millions$ 2,290  Millions

Date modified: 2023-05-06T20:55:06+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com